A number of research firms have changed their ratings and price targets for HubSpot (NYSE: HUBS): 10/14/2026 – HubSpot had its “hold” rating reaffirmed by UBS Group AG. 10/12/2026 – HubSpot was downgraded by Barclays PLC from “overweight” to “equal weight”. They now have a $240.00 price target on the stock. 10/12/2026 – HubSpot was […]

Several brokerages have updated their recommendations and price targets on shares of Regal Rexnord (NYSE: RRX) in the last few weeks: 10/15/2026 – Regal Rexnord had its “hold (c)” rating reaffirmed by Weiss Ratings. 10/12/2026 – Regal Rexnord had its price target lowered by Citigroup Inc. from $220.00 to $200.00. They now have a “buy” […]

Several analysts have recently updated their ratings and price targets for AutoNation (NYSE: AN): 10/7/2026 – AutoNation had its price target lowered by UBS Group AG from $248.00 to $213.00. They now have a “buy” rating on the stock. 10/6/2026 – AutoNation had its price target lowered by Barclays PLC from $260.00 to $230.00. They […]

Airbnb (NASDAQ: ABNB) has recently received a number of price target changes and ratings updates: 10/12/2026 – Airbnb had its “outperform” rating reaffirmed by Sanford C. Bernstein. 10/8/2026 – Airbnb was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”. 10/7/2026 – Airbnb had its price target lowered by Wells Fargo & Company from […]

C3.ai (NYSE: AI) has recently received a number of price target changes and ratings updates: 10/12/2026 – C3.ai was given a new $16.00 price target by Northland Securities. They now have an “outperform” rating on the stock. 10/12/2026 – C3.ai was upgraded by Northland Securities from “market perform” to “outperform”. They now have a $16.00 […]

Several brokerages have updated their recommendations and price targets on shares of First Hawaiian (NASDAQ: FHB) in the last few weeks: 10/5/2026 – First Hawaiian had its price target lowered by TD Cowen from $31.00 to $28.00. They now have a “hold” rating on the stock. 10/2/2026 – First Hawaiian had its “buy (b)” rating […]

Terreno Realty (NYSE: TRNO) recently received a number of ratings updates from brokerages and research firms: 10/12/2026 – Terreno Realty had its price target lowered by Piper Sandler from $91.00 to $85.00. They now have an “overweight” rating on the stock. 10/12/2026 – Terreno Realty was upgraded by BMO Capital Markets from “market perform” to […]

A number of firms have modified their ratings and price targets on shares of Dutch Bros (NYSE: BROS) recently: 10/15/2026 – Dutch Bros had its price target lowered by Stephens from $80.00 to $65.00. They now have an “overweight” rating on the stock. 10/15/2026 – Dutch Bros had its price target lowered by Morgan Stanley […]

ArriVent BioPharma (NASDAQ: AVBP) recently received a number of ratings updates from brokerages and research firms: 10/16/2026 – ArriVent BioPharma had its “buy” rating reaffirmed by BTIG Research. They now have a $29.00 price target on the stock. 10/15/2026 – ArriVent BioPharma had its “sell (d-)” rating reaffirmed by Weiss Ratings. 10/10/2026 – ArriVent BioPharma […]

O-I Glass (NYSE: OI) recently received a number of ratings updates from brokerages and research firms: 10/13/2026 – O-I Glass had its price target lowered by Royal Bank Of Canada from $8.00 to $7.00. They now have a “sector perform” rating on the stock. 10/12/2026 – O-I Glass had its price target lowered by Truist […]

Several brokerages have updated their recommendations and price targets on shares of Repligen (NASDAQ: RGEN) in the last few weeks: 10/8/2026 – Repligen was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”. 10/7/2026 – Repligen had its price target raised by Barclays PLC from $175.00 to $225.00. They now have an “overweight” rating […]

Several brokerages have updated their recommendations and price targets on shares of Halozyme Therapeutics (NASDAQ: HALO) in the last few weeks: 10/16/2026 – Halozyme Therapeutics was given a new $130.00 price target by Stifel Nicolaus. 10/13/2026 – Halozyme Therapeutics was upgraded by Zacks Research from “hold” to “strong-buy”. 10/13/2026 – Halozyme Therapeutics had its price […]

Flagstar Bank, National Association (NYSE: FLG) recently received a number of ratings updates from brokerages and research firms: 10/14/2026 – Flagstar Bank, National Association had its price target lowered by Cantor Fitzgerald from $17.00 to $16.00. They now have an “overweight” rating on the stock. 10/9/2026 – Flagstar Bank, National Association had its price target […]